Royal Fund Management’s Omega Healthcare OHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.93M | Buy |
40,532
+1,022
| +3% | +$47.4K | 0.16% | 147 |
|
|
2026
Q1 | $1.73M | Sell |
39,510
-903
| -2% | -$41.2K | 0.16% | 151 |
|
|
2025
Q4 | $1.79M | Buy |
40,413
+10,415
| +35% | +$449K | 0.16% | 136 |
|
|
2025
Q3 | $1.27M | Sell |
29,998
-7,214
| -19% | -$291K | 0.15% | 145 |
|
|
2025
Q2 | $1.36M | Buy |
37,212
+3,805
| +11% | +$141K | 0.14% | 174 |
|
|
2025
Q1 | $1.27M | Buy |
33,407
+1,326
| +4% | +$49.3K | 0.14% | 174 |
|
|
2024
Q4 | $1.21M | Sell |
32,081
-28,653
| -47% | -$1.14M | 0.11% | 173 |
|
|
2024
Q3 | $2.47M | Buy |
60,734
+28,329
| +87% | +$1.07M | 0.15% | 144 |
|
|
2024
Q2 | $1.11M | Sell |
32,405
-5,050
| -13% | -$159K | 0.09% | 183 |
|
|
2024
Q1 | $1.19M | Buy |
37,455
+1,799
| +5% | +$54.7K | 0.12% | 187 |
|
|
2023
Q4 | $1.09M | Buy |
35,656
+369
| +1% | +$11.8K | 0.12% | 182 |
|
|
2023
Q3 | $1.17M | Buy |
35,287
+537
| +2% | +$17.2K | 0.16% | 153 |
|
|
2023
Q2 | $1.07M | Sell |
34,750
-3,433
| -9% | -$99.2K | 0.13% | 158 |
|
|
2023
Q1 | $1.05M | Buy |
38,183
+4,668
| +14% | +$130K | 0.15% | 150 |
|
|
2022
Q4 | $937K | Buy |
33,515
+4,625
| +16% | +$139K | 0.15% | 125 |
|
|
2022
Q3 | $851K | Buy |
28,890
+4,655
| +19% | +$146K | 0.15% | 118 |
|
|
2022
Q2 | $683K | Buy |
24,235
+9,804
| +68% | +$279K | 0.11% | 129 |
|
|
2022
Q1 | $449K | Buy |
14,431
+2,410
| +20% | +$71.1K | 0.07% | 151 |
|
|
2021
Q4 | $355K | Buy |
12,021
+1,333
| +12% | +$38.9K | 0.05% | 154 |
|
|
2021
Q3 | $320K | Buy |
10,688
+838
| +9% | +$28.8K | 0.05% | 152 |
|
|
2021
Q2 | $357K | Buy |
9,850
+599
| +6% | +$22.2K | 0.06% | 147 |
|
|
2021
Q1 | $338K | Buy |
9,251
+165
| +2% | +$6.07K | 0.06% | 144 |
|
|
2020
Q4 | $330K | Sell |
9,086
-641
| -7% | -$21.7K | 0.07% | 133 |
|
|
2020
Q3 | $291K | Sell |
9,727
-278
| -3% | -$8.68K | 0.07% | 130 |
|
|
2020
Q2 | $297K | Buy |
10,005
+1,814
| +22% | +$53.7K | 0.1% | 122 |
|
|
2020
Q1 | $217K | Buy |
8,191
+447
| +6% | +$17K | 0.09% | 134 |
|
|
2019
Q4 | $327K | Buy |
7,744
+1,172
| +18% | +$49.6K | 0.08% | 112 |
|
|
2019
Q3 | $274K | Sell |
6,572
-290
| -4% | -$11.3K | 0.08% | 109 |
|
|
2019
Q2 | $252K | Sell |
6,862
-504
| -7% | -$18.4K | 0.07% | 111 |
|
|
2019
Q1 | $281K | Buy |
7,366
+517
| +8% | +$19.2K | 0.09% | 106 |
|
|
2018
Q4 | $240K | Buy |
6,849
+63
| +0.9% | +$2.19K | 0.1% | 95 |
|
|
2018
Q3 | $222K | Sell |
6,786
-3,018
| -31% | -$96.1K | 0.07% | 111 |
|
|
2018
Q2 | $303K | Buy |
9,804
+707
| +8% | +$20.2K | 0.1% | 92 |
|
|
2018
Q1 | $245K | Buy |
9,097
+4,167
| +85% | +$111K | 0.09% | 105 |
|
|
2017
Q4 | $135K | Buy |
4,930
+417
| +9% | +$12K | 0.05% | 133 |
|
|
2017
Q3 | $144K | Buy |
4,513
+474
| +12% | +$15.2K | 0.06% | 99 |
|
|
2017
Q2 | $133K | Buy |
4,039
+1,785
| +79% | +$59.1K | 0.06% | 99 |
|
|
2017
Q1 | $74K | Buy |
2,254
+117
| +5% | +$3.76K | 0.04% | 126 |
|
|
2016
Q4 | $66K | Buy |
+2,137
| New | +$66K | 0.04% | 131 |
|
Other funds holding OHI
AT
COPPSERS
GIM
CM
RRWA
CE
CPC
SOADOR
Royal Fund Management's OHI Position: Q2 2026 in Review
Royal Fund Management increased its Omega Healthcare (OHI) stake by 2.6% in Q2 2026, buying an estimated $47.4K and bringing the position to 40,532 shares worth $1.93M. The position accounts for 0.16% of the portfolio, ranked #147.
Royal Fund Management first reported a position in OHI in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.47M in Q3 2024. 195 funds tracked by Wall St. Rank hold OHI as of Q2 2026.
- Royal Fund Management held 40,532 shares of Omega Healthcare worth $1.93M as of Q2 2026.
- Royal Fund Management bought 1,022 Omega Healthcare shares in Q2 2026, an estimated $47.4K.
- Omega Healthcare made up 0.16% of Royal Fund Management's portfolio in Q2 2026, its #147 holding.
- Royal Fund Management first reported a position in Omega Healthcare in Q4 2016 and has held it in 39 quarters since.
- Royal Fund Management's Omega Healthcare position peaked at $2.47M in Q3 2024.
- 195 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.
Based on Royal Fund Management's 13F filing for Q2 2026, filed 20 Jul 2026.